These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. In vivo imaging of oligonucleotidic aptamers. Tavitian B; Ducongé F; Boisgard R; Dollé F Methods Mol Biol; 2009; 535():241-59. PubMed ID: 19377991 [TBL] [Abstract][Full Text] [Related]
29. Bioluminescence imaging to evaluate infections and host response in vivo. Contag PR Methods Mol Biol; 2008; 415():101-18. PubMed ID: 18370150 [TBL] [Abstract][Full Text] [Related]
30. Validating tyrosinase homologue melA as a photoacoustic reporter gene for imaging Escherichia coli. Paproski RJ; Li Y; Barber Q; Lewis JD; Campbell RE; Zemp R J Biomed Opt; 2015 Oct; 20(10):106008. PubMed ID: 26502231 [TBL] [Abstract][Full Text] [Related]
31. In Vivo Fluorescence Reflectance Imaging with Subcutaneous Mouse Tumor Models. Cao J; Zhou M Methods Mol Biol; 2016; 1444():27-35. PubMed ID: 27283414 [TBL] [Abstract][Full Text] [Related]
32. New Mouse Model for Chronic Infections by Gram-Negative Bacteria Enabling the Study of Anti-Infective Efficacy and Host-Microbe Interactions. Pletzer D; Mansour SC; Wuerth K; Rahanjam N; Hancock RE mBio; 2017 Feb; 8(1):. PubMed ID: 28246361 [TBL] [Abstract][Full Text] [Related]
33. [Necrotizing skin and soft tissue infections: definitions, clinical and microbiological features]. Gauzit R Ann Fr Anesth Reanim; 2006 Sep; 25(9):967-70. PubMed ID: 16675192 [TBL] [Abstract][Full Text] [Related]
34. Deep-red fluorescent imaging probe for bacteria. White AG; Gray BD; Pak KY; Smith BD Bioorg Med Chem Lett; 2012 Apr; 22(8):2833-6. PubMed ID: 22424976 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections. File TM; Tan JS Eur J Surg Suppl; 1994; (573):51-5. PubMed ID: 7524796 [TBL] [Abstract][Full Text] [Related]
36. Non-mammalian animal models to study infectious disease: worms or fly fishing? O'Callaghan D; Vergunst A Curr Opin Microbiol; 2010 Feb; 13(1):79-85. PubMed ID: 20045373 [TBL] [Abstract][Full Text] [Related]
37. Immune subversion and quorum-sensing shape the variation in infectious dose among bacterial pathogens. Gama JA; Abby SS; Vieira-Silva S; Dionisio F; Rocha EP PLoS Pathog; 2012 Feb; 8(2):e1002503. PubMed ID: 22319444 [TBL] [Abstract][Full Text] [Related]
38. Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam. Castaldo N; Givone F; Peghin M; Righi E; Sartor A; Bassetti M J Glob Antimicrob Resist; 2017 Jun; 9():100-102. PubMed ID: 28495526 [TBL] [Abstract][Full Text] [Related]
39. Engineering NIR dyes for fluorescent lifetime contrast. Berezin MY; Lee H; Akers W; Guo K; Goiffon RJ; Almutairi A; Fréchet JM; Achilefu S Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():114-7. PubMed ID: 19964923 [TBL] [Abstract][Full Text] [Related]
40. New directions using reporter enzyme fluorescence (REF) as a tuberculosis diagnostic platform. Sule P; Tilvawala R; Behinaein P; Walkup GK; Cirillo JD Tuberculosis (Edinb); 2016 Dec; 101S():S78-S82. PubMed ID: 27729258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]